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In the present study, a mucoadhesive non-woven fiber mat (d= 116 nm) was fabricated by the 
electrospinning method using chitosan (80% Wt), polyethylene oxide (10% Wt), cysteine (4% Wt) and 
drugs (6% Wt), respectively. In addition, a comparative study was conducted to define effect of drugs and 
mucoadhesive agent on the nanofiber formation. FTIR, SEM, DSC and DMA were used to investigate 
the chemical and physical properties of the nanofibers. In vitro release of the drugs was assessed over 
a 48-hour period by the total immersion method. Release data were fitted to kinetic models, including 
the zero-order, first-order, Higuchi matrix, and Hixson–Crowell. Zone inhibition investigations were 
used to describe the inhibition content of vancomycin and amphotericin B loaded in the mats. The 
SEM images displayed a slight decrease in the fiber diameter with adding drugs and mucoadhesive 
agents. FTIR spectra confirmed that any undesirable reaction between VAN–AMB and CS-PEO was 
not observed. DSC test recognized the uniform distribution of drugs in the polymeric bead of the fiber 
without any crystal form. The elasticity modulus of the nanofiber was in an acceptable range for oral 
mucosa (approximately 5 Mpa). The results indicated that biodegradable mucoadhesive nanofibrous 
membranes released high concentrations of VAN in the first 24 hours, but the AMB release was affected 
in more controlled phenomena.
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INTRODUCTION 
Recurrent aphthous stomatitis (RAS) is the second 
prevalent disease of the oral mucosa causing painful and 
recurrent necrotic lesions in oral mucosa tongue and gums 
(Passaretti et al., 2001). Lacking exact and complete 
prophylactic therapy has led to development of several 
treats using various agents such as drugs, antibacterial, 
anti-acidic and antineoplastic materials (Chiu, Tsai, 
2011). Histologically, RAS is caused by infiltration of 
mononuclear cells with fibrin coat (Ma et al., 2005). 
Although the lesions improve spontaneously after 10-14 
days, specific treatment should be considered owing to 
severe pain and possible recreation (Costa-Pinto, Reis, 
Neves, 2011). Esters, chemical and physical trauma, use 
of cancer drugs, food allergy and infection exacerbate 
the indisposition (Brooks et al., 2013). Mucoadhesive 
drug delivery systems (MDDS) have been extensively 
developed to treat oral diseases. In MDDS, drugs without 
first liver pass enter into the systemic circulation, which 
can lead to reduced dosage and side effects. Concerning 
antibiotics, it also can reduce antimicrobial resistance (Lu 
et al., 2012). 
In this study, mucoadhesive nanofibers were loaded 
with amphotericin-B (AMB) as the curing agent of 
fungi and vancomycin (VAN) as a barrier agent. AMB 
is a poly-N antibiotic with a similar structure to nystatin. 
Poly-N molecules are considered amphipathic, since 
they contain hydrophilic and lipophilic fragments. These 
molecules bind to ergosterol (a specialized cell membrane 
sterols fungus) and create artificial pores. The drug is 
poorly absorbed from the gastrointestinal tract. Usually, it 
is injected in the form of a colloidal non-lipid suspension 
widely distributed in all tissues. The half-life of AMB is 
approximately 2 weeks excreted mainly via a slow hepatic 
metabolism. Its mechanism of action is due to its effect 
on permeability and transmission characteristics of fungal 
membranes (Hamill, 2013). Vancomycin is commonly 
utilized in treating gram-positive microorganism 
dangerous infections (such as methicillin-resistant iD
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of staphylococci). VAN is not absorbed from the 
gastrointestinal tract. In the injectable form diffuses into 
the most tissues where excretes unchanged through urine. 
The side effects of VAN include chills, fever, phlebitis 
and so forth. Dose and controlled release behavior of 
antibiotics and it is so important. Nanotechnology helps to 
manipulate physical and chemical properties of materials; 
therefore, the demand changes are applied on the DDS. 
Nowadays, electrospinning as a versatile and flexible 
method is useful to make nanofibrous mats with the highest 
surface to volume ratio. Increasing the active surface 
reduces the dosage of the drugs. In electrospinning, high 
voltage is applied to create electrostatic forces overcoming 
viscosity and surface tension of the initial solution (a 
mixture of polymer, solvent, and drugs). After formation 
of the first jet, the solvent evaporates and solid nanofibers 
gather on the surface of collector (Li, Xia, 2004). 
Recent research introduces a mucoadhesive patch 
of chitosan (CS), polyethylene oxide (PEO) and cysteine 
(Cys) loaded with VAN and AMB. In the present study, 
we used chitosan as a non-toxic, biocompatible and 
biodegradable polymer. The existence of amine groups 
gives a cationic property to the CS solutions, causing 
problems in the electrospinning process. (Li, Xia, 2004; 
Puppi et al., 2010). Anionic or nonionic polymers are 
usually used a modifier agent. PEO is a synthetic nontoxic, 
nonionic, hydrophilic, mucoadhesive and lubricant 
polymer (Ma, Deng, Chen, 2013; Cannon, Long, 2008; 
Fullana, Wnek, 2012).
MATERIAL AND METHODS
Material
Chitosan (CS) (low molecular weight, DD: 91.2%, 
Viscosity: 220 mPa) was purchased from Hocheon 
Co. (China). Polyethylene oxide, Glacial acetic acid, 
acetone, absolute ethanol, NaOH, KH2PO4, Vancomycin, 
Amphotericin-B and cellulose acetate membrane were 
obtained from Sigma Aldrich (USA). 
Electrospinning Procedures
The spinal solutions were prepared as CS: PEO 
(80: 20) wt%, CS: PEO: Cys (80: 19: 1) wt%, CS: PEO: 
VAN: AMB (80:10:5:5) wt%, CS: PEO: VAN: AMB: 
Cys (80:10:4:4:2) wt% adding to the solvent mixture 
contain of acetic acid: water (80:20) wt%. Each solution 
was stirred for 24 h at room temperature. Cysteine as a 
mucoadhesive agent was added to the above solution in 
different concentrations (1, 2 and 3 %W/W of polymers). 
Vancomycin was added to the above mixture in the 8% 
W/W for drug loading. Herein, the electrospinning setup 
consisted of a syringe pump, a drum collector covered 
by an aluminum sheet and a high voltage supply. A 
plastic syringe (capacity =1 mL) was fuelled with CS/
PEO solution equipped with an 18-gauge needle. The tip 
of the needle was connected to the high voltage supply 
and placed in front of the drum collector with opposite 
charge. For electrospinning process, different parameters, 
including drum rotating speed (varied from 300 to 750 
rpm), volumetric flow rate (0.5 to 2.5 mL/h), distance 
between nozzle and drum (varied from 120 to 200 mm), 
temperature (20 to 45 oC) and applied voltage (12 to 22 kV) 
were investigated. Table I shows the obtained optimum 
parameter for electrospinning.
Cross-linking of nanofiber
To enhance mechanical properties of chitosan 
nanofibers, a 50 % Wt solution of glutaraldehyde (GTA) 
was used in water. 10 mL of this solution was poured in a 
petri dish and placed in vacuumed desiccator for 2 h, then 
it moved to a vacuum oven with a temperature of 40 °C 
for 24 h to eliminate the unreacted GTA from the nanofiber 
mats (Hargreaves, Nguyen & Ryan, 2006).
Apparatus
The electrospun nanofibers were characterized with 
SEM (Philips XL30 microscope), FTIR (Schimadzu IR-
prestige 21), DSC (Mettler Toledo STAR system, DSC821, 
Columbus, Ohio), and DMA (STM 50).
In vitro release and kinetics study
The immersion method was investigated in vitro 
release of VAN and AMB from nanofibrous membrane. 
TABLE I - Optimum conditions for electrospinning
Temperature [oC] Distance spinneret collector [mm] Voltage [KV]
Solution flow 
rate [mL/h]
Concentration  
[%^w/t]
38 - 40 120 15 - 20 1.2 2/7
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Approximately 50 mg of the electrospun fibers was placed 
in to the dialysis bag (SERVA, MWCO, 12000 Da), 
2 mL PBS (pH = 7.4) was added to each bags; this part 
acted as the donor solution. The bag was immersed in 50 
mL of receptor medium (phosphate buffer saline 0.2 M, 
pH 7.4) and incubated at 37oC under magnetic stirring 
(approximately 400 rpm). At specified time intervals, 1 mL 
of solution was taken and replaced with the same volume 
of fresh buffer. For drug concentration assay, the taken 
samples were analyzed at 283 nm and 416 nm for VAN 
and AMB using a UV spectrophotometer (UVmini-1240, 
Shimadzu, Germany) (Rostami, Kashanian, Azandaryani, 
2014). The quantity of the drug released was calculated 
according to Equation 1:
  (1)
where Cn is the concentration of the released drug, C 
is the concentration in the withdraw sample, Cn-1 is 
the concentration of the drug in the n-1 sample, V and 
Vt are the picked up and the total volume of receptor 
solution, respectively. The release results are plotted as 
the cumulative percentage of drug content in solution 
vs time.
For in vitro study of release kinetics, several 
approaches can be used such as analysis of variance, 
model-independent, and model-dependent approaches. 
In this study, model-dependent approaches were used 
to compare dissolution profiles. In model-dependent 
approaches, release data were fitted to kinetic models, 
including the zero-order (Eq. 2), first-order (Eq. 3), 
Higuchi matrix (Eq. 4), Hixson–Crowell (Eq. 5) release 
equations to find the equation with the best fit (Rostami, 
Kashanian, Azandaryani,  2014; Venkateswarlu, 
Manjunath, 2004).
 C = K0t (2)
 Log C= Log C0 – Kt/2.303 (3)
 Q= Kt½ (4)
  (5)
Antibacterial properties characterization
The antibacterial activities of CS/PEO nanofibrous 
layers with and without VAN/AMB were investigated in 
the presence of gram-positive streptococcus (Strep.) by 
the zone inhibition method. An 8 mm diameter circular 
was cut from each mat and sterilized by placing under 
UV radiation for 20 min. Then, they were transferred 
to bacterium suspension then incubated for 24 hours at 
37 °C. The zone of inhibition was measured by testing the 
diameter of inhibition part round each circle.
RESULT AND DISCUSSION
Morphology of electrospun nanofiber 
The morphology and structure of different 
nanofibrous mats containing CS/PEO, CS/PEO/Cys, CS/
PEO/Drugs and CS/PEO/Cys/Drugs were investigated by 
scanning electron microscopy (SEM). Before the analysis, 
the samples were dried and coated with a gold layer for 12 
hours. Freshly prepared fibers were used to obtain SEM 
images. Figure 1 presents the fibers (A-H). 
SEM micrograph of CS/PEO
Figure 1 (A, B) displays various magnifications of 
the CS/PEO nanofibers of SEM micrographs. The surface 
of the fiber is soft and seems almost round. The average 
diameter was approximately 242 nm. It should be noted 
that the diameter ranged from 80-500, which is relatively 
wide-ranging. During the electrospinning process, since 
CS solution is a polycation one, the interaction between the 
electron donates and receiver causes the jet to breakdown 
for creating fine nanofibers.
SEM micrograph of CS/PEO/ Cys
Figure 1 (C, D) shows various magnifications 
of nanofibers and the histogram of fiber diameter 
distribution. The average diameter was approximately 
200 nm. The addition of Cys, a mucoadhesive agent, 
resulted in decrease of fiber size. Cys is an amino acid 
type two with polar and nonionic side chains capable 
of forming hydrogen bond, leading to increasing water 
solubility. The ionic characteristic efficiency depends 
on pH. 
SEM micrograph of CS/PEO/Drugs
After addition of the drugs into the polymeric 
solution, the fiber diameter was reduced to 118 nm, and 
a uniform distribution of fiber diameter was obtained. 
(Figure 1 (E, F).) 
SEM micrograph of CS/PEO/Cyc/ Drugs
Finally, the nanofibrous mat size was approximately 
116 nm, and a normal distribution was achieved. Bead 
formation and spider-like network events were obviously 
observed in the SEM micrographs (Figure 1 (G, H)).
Figure 2 summarizes type of nanofibers and their 
sizes.
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FIGURE 1 - SEM micrographs of (A, B) CS/PEO, (C, D) CS/PEO/Cys, (E, F) CS/PEO/Drugs and, (G, H) CS/ PEO/Cys/Drugs.
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Characterization of nanofibers
The fibers were characterized by using Fourier 
Transform Infrared spectroscopy (FT-IR). To measure the 
FT-IR spectrum of nanoparticles, 2 mg of the samples were 
mixed with 10 mg KBr and compressed into a tablet form. 
The IR spectra of these tablets were obtained in a transition 
mode and in the spectral region of 400 to 4000 cm−1. As 
Figure 3 shows, the IR spectra of samples were recorded 
in a transition mode and in the spectral region of 450 to 
4000 cm−1.The peaks of 3359, 2850, 1593 cm-1 belong 
to –COOH, C-H and –NH2 groups of chitosan (Chen et 
al., 2001). The peaks at 1658, 1500, 1235, 1126 and 1064 
cm-1 belong to C=C, carbonyl, C-O-C and –C-N groups of 
VAN and AMB (Moreno & Salgado, 2012). The presence 
of weak spectra in the range of 400 to 500 cm-1 indicates 
the –S-H groups of Cys (Rath et al., 1994).
In the IR spectrum of CS/PEO, different peaks at 
3359, 2850, 3294 cm-1 shows carboxylic (–COOH), C-H, 
type two amide (N-H, C-H) respectively. Furthermore, 
a strong peak at 1680 cm-1, a shoulder at 1630 cm-1 and 
a peak at 1538 cm-1 correspond to C=O stretching of the 
N-acetyl group, scissor vibration of the amine group and 
ammonium (-NH3+) ions, respectively. The peak at 1049 
cm-1 is interpreted type one amine groups (R-NH2).
CS/PEO/VANCO spectrum exhibits C=C frequency 
at 1658.7 cm-1 and C=O at 1500.62 cm-1. The asymmetric 
C-O-C absorption occurs at approximately 1235 cm-1. C-N 
stretching bond was observed at 1260 and 1064 cm-1. C-O 
stretching vibration is observed in the range of 900-1350 as 
a broad peak, by the presence of this bond simple aliphatic 
ethers can be distinguished. Finally, C-Cl stretch in VAN 
structure (C66H75Cl2N9O24) appears at approximately 553 
cm-1. No peaks belong to undesirable interaction of drug 
and CS/PEO is detected. 
In the IR spectrum of CS/PEO/AMB, the bonds of 
CS and PEO are identified, and no unwanted reactions are 
found. The final CS/PEO solution, including the drugs and 
Cys, showed all the related peaks.
The weak peaks in the range of 400 to 500 cm-1 
confirm the –S-H groups of Cys.
For Differential Scanning Calorimetry (DSC) assay, 
the samples were sealed in aluminum pans under a nitrogen 
air atmosphere at a flow rate of 50 mL/min and evaluated 
in 0°C–300 °C temperature ranges. Figure 4 shows DSC 
thermograms for CS/PEO, CS/PEO/Cys, and CS/PEO/
drugs. The polymeric fibers showed a melting process with 
an onset temperature of 52 °C and a peak of 60 °C that might 
be related to the water evaporated from polymers structures. 
The chitosan and polyethylene oxide showed the exothermic 
peak at the temperature of 173 °C and 232 °C, respectively, 
which are due to the polymer decomposition. The peak 
temperatures are confirmed in solutions containing CS/
PEO/Cys, and CS/PEO/drugs. However, no melting process 
was observed for drugs (the melting peak of the drug must 
be shown in 215 °C in the fibers) (Kiondo et al., 2011). This 
phenomenon suggested that there was no crystalline form 
of the drugs in the fibers (Scapino, 1967).
Dynamical Mechanical Analysis (DMA) of CS/
PEO, CS/PEO/Cys, and CS/PEO/drugs nanofibers was 
FIGURE 2 - Comparison the diameter of the fibers. 
FIGURE 3 - FTIR spectra for CS/PEO, CS/PEO/Cys, CS/PEO/
Drugs, CS/ PEO/Cys/ drugs. 
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conducted under stress control mode by using STM 50 
instrument. The capabilities of the nanofibres to store 
energy during deformation are expressed in terms of 
storage modulus, representing the elastic component of a 
material. As Figure 5 shows, by increasing Cys or drug(s) 
to the fibers, the modulus value decreased. The fibers with 
the drug have modules of around 5000 Mpa. Fiber with 
this elasticity has a suitable property for mucosal therapy 
(Wong, Baji, Leng, 2008).
Also, for mechanical analysis, the tearing resistance 
was showed in Figure 6 for CS/PEO, CS/PEO/Cys, CS/
PEO/drugs and CS/PEO/Cys/drugs, respectively. The 
elongation characteristic of fiber increased with increase in 
drug concentration that is due to the molecular properties 
of the drug in comparison to polymers. With increasing the 
drugs and Cys, fiber diameter reduced approximately 50 % 
that led to interweaving fibers; therefore, the mechanical 
property improved (Schmitz et al., 2008).
Mucoadhesive properties
Mucoadhesion studies were conducted according 
to the rotating cylinder method. For this propose, 
mucoadhesive strength of the nanofibers to the oral 
mucosa was investigated in adult sheep (pH=6, at 37 °C). 
Various concentrations of Cys solution containing (1, 2.5 
and 5 %W/W of polymers) were used. The hydration of 
nanofibers had an important influence on the mucoadhesive 
strength. In the absence of proper hydration and excessive 
hydration, mucoadhesive property considerably reduced. 
Figure 7 shows the relation between Cys concentration and 
adhesive strength (Data are obtained using at least three 
experiments ± standard deviation) (Jia, 2005).
In vitro release and kinetic studies
Figure 8 exhibits the in vitro release profile of 
the drugs under sink conditions (PBS, pH=7.4). The 
concentration of the drugs was investigated by the HPLC 
method. The AMB released in the sustained form was 
continued to 100% for 24 hours and VAN had a fast release 
in the first two hours and was followed by 80 %. 
The fast release of the drug is highly important in 
mucoadhesive drug delivery systems, since it increases 
the patient’s compliance. The size of nanofiber has a 
FIGURE 4 - DSC thermograms of CS/PEO, CS/PEO/Cys, 
CS/ PEO/Cys/ Drugs.
FIGURE 6 - Mechanical analysis of CS/PEO, CS/PEO/Cys, 
CS/PEO/drugs and CS/PEO/Cys-drugs fibers.
FIGURE 5 - DMA analysis of free and drug-loaded nanofibers. 
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considerable effect on the release rate of drugs. Since a 
fiber with lower diameter often has higher drug release 
ratio, this behavior is explained by a corresponding 
increase in surface area to volume ratio. The release 
behavior of amphotericin B in 24 h was slow and 
continuous, leading to a uniform entrance of drug in blood 
circle and increasing its bioavailability (Schmitz et al., 
2008). VAN shows a fast release relative to AMB. It could 
be due to phase separation transferred to the surface of the 
fiber or accumulation of VAN molecules as larger units 
on the surface of fibers. The slow and continuous release 
of AMB could be due to compatibility of the polymers 
molecule with the drug.
The kinetic of the drugs was evaluated by the data 
(curve) fitting method. Various methods of drug release 
such as zero-order, first-order, Higuchi and Hixson–
Crowell kinetics were tested, then the most appropriate 
one was selected based on the regression value (R2). 
Table II reports the R2 and dissolution rate constant (K) 
of various kinetic models. Releasing of VAN behaves 
according to Higuchi, while AMB is followed zero-order 
equations. 
Antibacterial and antifungal activity of 
nanofibers 
The gram-positive streptococcus and candida 
albicans microorganisms were used for antimicrobial 
tests. The bacteria and fungus were incubated for the 
growth of microorganisms on the Muller Hilton and 
Sabouraud Dextrose agar, respectively. Then, the in vitro 
antibacterial activities of CS/PEO/Cys, CS/PEO/Vanco, 
CS/PEO/Cys/Vanco nanofibers and antifungal activities 
of CS/PEO/Cys, CS/PEO/AMB, CS/PEO/Cys/AMB 
nanofibers were examined by the disk diffusion method 
for 24 hours at 37 °C. The growth of microorganisms was 
inhibited owing to the antibiotics released in the solution. 
Figure 9 shows the antibacterial and anti-fungal effects 
of the fibers. 
The diameter of the inhibition zone, showing the 
diffusion ability of the drugs in the culture, was measured 
by a ruler (accuracy = 1mm), which is reported in Table III. 
Nanofiber without drugs as a control case, has no 
antibacterial or antifungal effects. Whereas CS/PEO/AMB 
nanofibers show the best inhibition efficiency. 
FIGURE 7 - Adhesion strength of nanofibrous mats versus 
various concentrations of Cys.
TABLE II - The R2 and release rate constant values from in vitro release kinetics
Formulas Zero order First order Higuchi model Hixon
AMB loaded Nanofibers K 0.0006 0.0017 42.873 0.0004
R2 0.991 0.906 0.954 0.964
VAN loaded Nanofibers K 0.0003 0.006 62.67 0.002
R2 0.776 0.872 0.915 0.842
R2: regression coefficient and k: dissolution rate constant 
FIGURE 8 - In vitro release profile of VAN and AMB.
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TABLE III - The diameter of the zone inhabitation surrounding the fibers
NO. CS + PEO + Cys CS+PEO+Cys+Van CS+PEO+Van CS+PEO+Ampho CS+PEO+Cys+Ampho
Mean±STD 0 57 ± 0.816 mm 60 ± 0.943 mm 9 ±0.471 10 ±0.474
FIGURE 9 - The antibacterial and anti-fungal effect of the drug-
loaded fibers. 
CONCLUSION
In  the  present  s tudy,  new chi tosan-based 
mucoadhesive nanofiber mats were proposed for the 
RAS test. The mats were simultaneously loaded by VAN 
and AMB as antibacterial and antifungal agents. Thus, 
the VAN and AMB were used simultaneously. The SEM 
images displayed a slight decrease in the fiber diameter 
with adding drugs and mucoadhesive agents. FTIR 
spectra confirmed that no undesirable reaction were 
observed between VAN–AMB and CS-PEO. The DSC 
test recognized the uniform distribution of drugs in the 
polymeric bead of the fiber without any crystal form. The 
elasticity modulus of the nanofiber was in an acceptable 
range for oral mucosa (about 5 Mpa). In vitro release 
profile of VAN was fitted by Higuchi model, whereas 
AMB was consistent with zero-order equations. The result 
showed that biodegradable mucoadhesive nanofibrous 
membranes released high concentrations of VAN in the 
first 24 hours, but the AMB release was affected in more 
controlled phenomena. The bioactivity of vancomycin 
ranged from 90% to 95%. The antibacterial and anti-
fungal experiments proved the efficiency of nanofibers. 
Moreover, the results indicated that the nanofibers were 
functionally active in the treatment of oral aphthous 
ulceration. 
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